CONMED Corporation CNMD
i
Market datapartial · fetched 2026-11-13T19:12:21.098Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T19:09:17.169125823Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-13T19:12:19.821458+00:00
CONMED Corporation options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 60.86 | 102.5% | 22.1% | |||
| 25Δ | 59.36 | 99.1% | 19.6% | |||
| 30Δ | 57.86 | 95.8% | 17.1% | |||
| 35Δ | 56.35 | 92.4% | 14.5% | |||
| 40Δ | 54.85 | 89.0% | 12.0% | |||
| 45Δ | 53.35 | 85.6% | 9.5% | |||
| 50Δ | 51.85 | 82.2% | 7.0% | |||
| 55Δ | 50.35 | 78.8% | 4.4% | |||
| 60Δ | ||||||
| 65Δ | ||||||
| 70Δ | ||||||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- 60.86
- IV
- 102.5%
- B/E move
- 22.1%
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- 59.36
- IV
- 99.1%
- B/E move
- 19.6%
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 57.86
- IV
- 95.8%
- B/E move
- 17.1%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 56.35
- IV
- 92.4%
- B/E move
- 14.5%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 54.85
- IV
- 89.0%
- B/E move
- 12.0%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 53.35
- IV
- 85.6%
- B/E move
- 9.5%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 51.85
- IV
- 82.2%
- B/E move
- 7.0%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 50.35
- IV
- 78.8%
- B/E move
- 4.4%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 40.50% | |
| 39.64% | |
| 43.12% | |
| 40.08% | |
| 41.58% | |
| 43.28% | |
| 44.93% | |
| 39.91% | |
| 36.55% | |
| 42.37% |
Medical Devices
CTKB
Cytek Biosciences Inc (CTKB) is a pioneering force in multi-parameter flow cytometry, delivering innovative cell analysis solutions that advance research in immunology, cancer…
More →CVRX
CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure.
More →DCTH
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company is…
More →DXCM
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with…
More →ELMD
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation (HFCWO) therapy in lung…
More →ENOV
Description unavailable
More →